Principal Financial Group’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-220,146
| Closed | -$36.4M | – | 2659 |
|
|
2021
Q2 | $36.4M | Sell |
220,146
-4,031
| -2% | -$673K | 0.02% | 579 |
|
|
2021
Q1 | $34.4M | Buy |
224,177
+30,853
| +16% | +$4.19M | 0.02% | 572 |
|
|
2020
Q4 | $24.3M | Buy |
193,324
+856
| +0.4% | +$95.7K | 0.02% | 657 |
|
|
2020
Q3 | $19.5M | Sell |
192,468
-6,403
| -3% | -$653K | 0.02% | 683 |
|
|
2020
Q2 | $19.3M | Buy |
198,871
+3,708
| +2% | +$345K | 0.02% | 667 |
|
|
2020
Q1 | $16.2M | Sell |
195,163
-81,204
| -29% | -$7.92M | 0.02% | 639 |
|
|
2019
Q4 | $30.7M | Buy |
276,367
+2,271
| +0.8% | +$234K | 0.03% | 565 |
|
|
2019
Q3 | $27.2M | Buy |
274,096
+10,272
| +4% | +$1.02M | 0.02% | 583 |
|
|
2019
Q2 | $26.2M | Sell |
263,824
-148,281
| -36% | -$14.2M | 0.02% | 611 |
|
|
2019
Q1 | $45.5M | Buy |
412,105
+2,294
| +0.6% | +$240K | 0.04% | 420 |
|
|
2018
Q4 | $37.7M | Sell |
409,811
-11,896
| -3% | -$1.2M | 0.04% | 431 |
|
|
2018
Q3 | $46.5M | Buy |
421,707
+11,230
| +3% | +$1.17M | 0.04% | 440 |
|
|
2018
Q2 | $38.3M | Buy |
410,477
+54,907
| +15% | +$4.73M | 0.04% | 480 |
|
|
2018
Q1 | $29.5M | Sell |
355,570
-40,162
| -10% | -$3.57M | 0.03% | 580 |
|
|
2017
Q4 | $36M | Buy |
395,732
+10,323
| +3% | +$859K | 0.03% | 507 |
|
|
2017
Q3 | $29.4M | Sell |
385,409
-25,426
| -6% | -$1.92M | 0.03% | 583 |
|
|
2017
Q2 | $30.8M | Sell |
410,835
-165,442
| -29% | -$11.5M | 0.03% | 556 |
|
|
2017
Q1 | $37.6M | Buy |
576,277
+18,391
| +3% | +$1.08M | 0.05% | 424 |
|
|
2016
Q4 | $30.8M | Buy |
557,886
+53,486
| +11% | +$2.94M | 0.04% | 485 |
|
|
2016
Q3 | $28.5M | Buy |
504,400
+35,719
| +8% | +$1.75M | 0.04% | 498 |
|
|
2016
Q2 | $19.6M | Sell |
468,681
-9,097
| -2% | -$419K | 0.03% | 621 |
|
|
2016
Q1 | $20.4M | Buy |
477,778
+3,075
| +0.6% | +$130K | 0.03% | 578 |
|
|
2015
Q4 | $21.5M | Sell |
474,703
-16,577
| -3% | -$696K | 0.03% | 534 |
|
|
2015
Q3 | $19.1M | Sell |
491,280
-12,073
| -2% | -$483K | 0.03% | 565 |
|
|
2015
Q2 | $18.3M | Buy |
503,353
+29,791
| +6% | +$942K | 0.03% | 623 |
|
|
2015
Q1 | $13.7M | Sell |
473,562
-1,038
| -0.2% | -$29K | 0.02% | 755 |
|
|
2014
Q4 | $11.5M | Buy |
+474,600
| New | +$10.7M | 0.02% | 857 |
|
Other funds holding PRAH
Principal Financial Group's PRAH Position: Q3 2021 in Review
Principal Financial Group sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 220,146 shares — an estimated $36.4M sold.
Principal Financial Group first reported a position in PRAH in Q4 2014 and held it in 27 quarters. The position peaked at $46.5M in Q3 2018. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- Principal Financial Group reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Principal Financial Group sold 220,146 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $36.4M.
- Principal Financial Group first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 27 quarters.
- Principal Financial Group's PRA Health Sciences, Inc. position peaked at $46.5M in Q3 2018.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on Principal Financial Group's 13F filing for Q3 2021, filed 9 Nov 2021.